GENE ONLINE|News &
Opinion
Blog

2022-07-28|

BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies

by Reed Slater
Share To

Hundreds of biotech startups pop up yearly, and their fate typically has three options. They can flourish into successful independent companies of their own, shrink and shutter in failure, or, most likely, make an exit through a merger or acquisition to a larger company. 

Timothy K. Lu, Co-founder, and CEO of Senti Biosciences, Inc., moderated the panel “Exit Strategies for Early Stage New Drug Companies” at BIO Asia-Taiwan 2022, which began July 27 with the theme of “Connecting the Asian Value Chain.” The event brings together biotechnology, pharmaceutical executives, and investors worldwide to explore business opportunities in Taiwan’s emerging biotech sector. 

During the panel, five respected industry experts provided their thoughts on startup exit strategies and the considerations for maneuvering within the biotech industry. The panelists issued their opinions on the importance of an initial plan when starting a company, the opportunities and limitations of cross-border investments, and sufficient international patent protection in a globalized world. 

It's free! Log in now to read

LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top